Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis

Although piperacillin-tazobactam (TZP) was shown to be less effective than carbapenems in treating bacteremia due to extended-spectrum β-lactamase-producing (ESBL)-producing organisms in a randomized controlled trial, the fact that many of the causative organisms co-produced inhibitor-resistant OXA-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoashi, Kosuke, Hayama, Brian, Suzuki, Masahiro, Sakurai, Aki, Takehana, Kazumi, Enokida, Taisuke, Takeda, Koichi, Ohkushi, Daisuke, Doi, Yohei, Harada, Sohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430612/
https://www.ncbi.nlm.nih.gov/pubmed/35916524
http://dx.doi.org/10.1128/spectrum.02206-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430612/
https://www.ncbi.nlm.nih.gov/pubmed/35916524
http://dx.doi.org/10.1128/spectrum.02206-22

Ejemplares similares